Literature DB >> 27916544

Characterization of Escherichia coli causing community acquired urinary tract infections in Mexico City.

Laura Belmont-Monroy1, Rosa María Ribas-Aparicio2, Armando Navarro-Ocaña3, H Ángel Manjarrez-Hernández4, Sandra Gavilanes-Parra4, Gerardo Aparicio-Ozores2, Patricia Isidra Cauich-Sánchez2, Ulises Garza-Ramos5, José Molina-López6.   

Abstract

The O25-ST131 clone was identified within 169 uropathogenic Escherichia coli (UPEC) strains. The 44.8% of the 29 O25-ST131 clones detected were positive to least to one extended-spectrum β-lactamase gene. The phylogroup D was mainly found. The O25-ST131 clone appeared to be associated with community-acquired UTI in Mexico City.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Escherichia coli; Multiplex PCR; ST131 clone; Serogroups; Urinary infection

Mesh：

Substances：

Year:  2016        PMID： 27916544     DOI： 10.1016/j.diagmicrobio.2016.11.006

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN： 0732-8893            Impact factor:   2.803


  3 in total

1.  Comparative Study of CTX-M-15 Producing Escherichia coli ST131 Clone Isolated from Urinary Tract Infections and Acute Diarrhoea.

Authors:  Soha S Abdelrahim; Magdy Fouad; Nilly Abdallah; Rasha F Ahmed; Shaimaa Zaki
Journal:  Infect Drug Resist       Date:  2021-09-29       Impact factor: 4.003

2.  |Isolation and characterization of novel bacteriophages as a potential therapeutic option for Escherichia coli urinary tract infections.

Authors:  Edgar González-Villalobos; Rosa María Ribas-Aparicio; Gerardo Erbey Rodea Montealegre; Laura Belmont-Monroy; Yerisaidy Ortega-García; Gerardo Aparicio-Ozores; José Luis Balcázar; Carlos Alberto Eslava-Campos; Ulises Hernández-Chiñas; José Molina-López
Journal:  Appl Microbiol Biotechnol       Date:  2021-07-12       Impact factor: 4.813

3.  Detection of CMY-type beta-lactamases in Escherichia coli isolates from paediatric patients in a tertiary care hospital in Mexico.

Authors:  Jocelin Merida-Vieyra; Agustín De Colsa-Ranero; Yair Calderón-Castañeda; Alejandra Aquino-Andrade
Journal:  Antimicrob Resist Infect Control       Date:  2020-10-29       Impact factor: 4.887
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.